Table 1.
Nuclear Receptor | Nuclear Receptor Responsive Element | Natural Ligands | Synthetic Ligands | Function: Lipogenesis Versus Fatty Acid Oxidation | Function: Liver Regeneration |
---|---|---|---|---|---|
PPARα | 5′-AGGTCA(N)AGGTCA-3′ | Free fatty acids Fatty acid derivatives |
Fibrates Wy-14,643 Ciprofibrates |
Increases fatty acid oxidation | Increases |
PPARγ | 5′-AGGTCA(N)AGGTCA-3′ | Free fatty acids Fatty acid derivatives |
Glitazones | Increases lipid storage/lipogenesis | Increases |
LXRα,β | 5′-(A/G)G(G/T)T(C/T)Annnn-(A/G)G(G/T)T(C/T)A-3′ | Oxysterols | T0901317 GW3965 |
Increases lipogenesis | Decreases |
FXR | 5′-AGAGCA(N)AGGGGA-3′ | Bile acids Oxysterols Polyunsaturated fatty acids |
GW4064 6ECDCA MFA1 Obeticholic acid |
Decreases lipogenesis | Increases |
CAR | 5′-(A/G)GTTCAnnnn-(A/G)GTTCA-3′ | Xenobiotics Androstenol |
Phenobarbital TCPOBOP Antimalarial drug artemisinin |
Decreases lipogenesis/increases fatty acid oxidation | Increases |
PXR | 5′-(A/G)GTTCAnnnn-(A/G)GTTCA-3′ | Bile acids Cholesterol derived 5-cholestane-3, 7, 12-triol |
Drugs Xenobiotics |
Decreases lipogenesis/fatty acid oxidation | Increases |
TR | 5′-(A/G)GGTCAnnnn-(A/G)GGTCA-3′ | T3 and T4 | CO23,GC-1 KB-141 KB2115 MB07811 |
Increases fatty acid oxidation | Increases |